Citrus Grandis (grapefruit) extract is a natural bioactive derived from the peel and pulp of grapefruit, widely used for its antioxidant, anti‑inflammatory and flavoring properties in food, beverage, nutraceutical and personal‑care formulations. The Citrus Grandis (Grapefruit) Extract market size reached approximately USD 300 million in the base year 2025, and industry analysts project a growth outlook with a compound annual growth rate (CAGR) of about 5.5% through the 2026‑2033 market forecast period, reflecting robust industry expansion driven by rising consumer demand for clean‑label ingredients, functional health benefits, and the surge in natural‑based product development. Key macro drivers include heightened wellness awareness, regulatory incentives for natural additives, and the scalability of sustainable extraction technologies. The market is shaped by three primary forces: (1) advanced extraction methods such as super‑critical CO₂ improving potency and yield, (2) tightening food‑safety and labeling regulations that favor natural extracts, and (3) evolving supply‑chain dynamics linked to seasonal citrus harvests. North America remains the largest region, while Asia‑Pacific is emerging as the fastest‑growing market.